Tim Keyes
About Tim Keyes
Tim Keyes serves as the Senior Director of U.S. Value, Access, and Pricing Strategy at Kite Pharma, where he has developed significant capabilities in financial forecasting and market access. He has previously held key finance roles at Pfizer, Hospira, and bluebird bio, contributing to major product launches and strategic initiatives in the pharmaceutical industry.
Work at Kite Pharma
Tim Keyes serves as the Senior Director of U.S. Value, Access, and Pricing Strategy at Kite Pharma since 2021. In this role, he focuses on developing strategies to enhance market access and optimize pricing for Kite's products. He has created a market segmentation tool that connects individual payers and providers by region, facilitating effective strategy setting and field execution. Additionally, he co-chairs a market access strategy team that includes over 25 colleagues, emphasizing collaboration and strategic alignment within the organization.
Previous Experience at Pfizer
Before joining Kite Pharma, Tim Keyes worked at Pfizer as the Head of Finance for U.S. Biosimilars from 2015 to 2019. During his tenure, he built a finance team that established Pfizer's first specialty biologic analytic capabilities and infrastructure. He led the development of a strategic decision framework and financial forecast for Pfizer's first 'at risk' product launch amid ongoing intellectual property litigation. He also developed site of care performance reporting and buy-and-bill financial forecasting capabilities, and successfully presented financial valuations to Pfizer's CEO and CFO, which enabled the launch of Inflectra.
Career at bluebird bio
Tim Keyes held the position of Senior Director, U.S. Market Access Strategy, Pricing, and Contracting Lead at bluebird bio from 2019 to 2021. In this role, he was responsible for developing and implementing market access strategies that aligned with the company's objectives. His experience in pricing and contracting contributed to the overall success of bluebird bio's market initiatives during his two-year tenure.
Education and Expertise
Tim Keyes earned a Bachelor of Arts degree in Accounting and Finance from Carthage College, where he studied from 2007 to 2011. His educational background provides a strong foundation for his expertise in finance, market access, and pricing strategy within the pharmaceutical industry. This academic experience, combined with his extensive professional background, equips him with the skills necessary to navigate complex financial landscapes and contribute to strategic decision-making.
Early Career at Hospira
Tim Keyes began his career at Hospira, where he worked as a Senior Cost Analyst in the Manufacturing Site from 2011 to 2015. In this role, he focused on cost analysis and financial reporting, which helped him develop a solid understanding of manufacturing processes and financial management within the healthcare sector. His experience at Hospira laid the groundwork for his subsequent roles in finance and market access.